trending Market Intelligence /marketintelligence/en/news-insights/trending/bwjhnyclsvumvry2gbkcxg2 content esgSubNav
In This List

Osiris Therapeutics CFO resigns; interim replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Osiris Therapeutics CFO resigns; interim replacement named

Osiris Therapeutics Inc. said Linda Chang resigned as the company's CFO.

The Columbia, Md.-based maker of regenerative medicine named Joel Rogers interim CFO.

Rogers has been Osiris Therapeutics' corporate controller since October 2017, and was previously corporate controller at industrial equipment maker ARC Group Worldwide, Inc.